Therapy Areas: Oncology
AstraZeneca to invest USD2bn in major Maryland manufacturing expansion
24 November 2025 - AstraZeneca PLC (LSE: AZN) (STO: AZN) (Nasdaq: AZN) declared on Monday that it will invest USD2bn to expand its manufacturing footprint in Maryland, adding capacity at its Frederick...
Vaximm enters non-binding term sheet with BCM Europe
24 November 2025 - OSR Holdings Inc (NASDAQ: OSRH), a US-based global healthcare holding company that is involved in advancing biomedical innovations in healthcare and wellness, announced on Friday th...
Abbott agrees to acquire Exact Sciences
21 November 2025 - US-based global healthcare company Abbott (NYSE:ABT) announced on Thursday that it has signed a definitive agreement to acquire molecular diagnostics company Exact Sciences (NASDAQ:...
Nuvalent's zidesamtinib NDA filing accepted by US FDA
20 November 2025 - Clinical-stage biopharmaceutical company Nuvalent Inc (Nasdaq:NUVL) said on Wednesday that the US Food and Drug Administration (FDA) has accepted for filing its New Drug Application...
Hemispherian secures US patent allowance expanding GLIX1 patent protection
19 November 2025 - Norwegian biotechnology company Hemispherian AS announced on Wednesday that the US Patent and Trademark Office has issued a Notice of Allowance for its patent application covering u...
AbbVie receives approval for EPKINLY, rituximab and lenalidomide combination
19 November 2025 - US-based pharmaceutical company AbbVie (NYSE:ABBV) announced on Tuesday that it has received approval from the US Food and Drug Administration for EPKINLY (epcoritamab-bysp), a T-ce...